“BenefitsLink continues to be the most valuable resource we have at the firm.”
-- An attorney subscriber
|A Framework for Categorizing and Analyzing Prescription Drug Pricing Reform Options|
The Brookings Institution
Aug. 31, 2021
"[P]olicymakers should think about reform options as fitting within three sets of categories:  those focusing on patients' out-of-pocket costs;  those targeting problematic incentives for various stakeholders within the system; and  those addressing the high prices of particular drugs."
|Please click here to report this link if it is broken (for example, if you see a "404 File Not Found" error message after you click on the link above).|
|An important word about authorship: BenefitsLink® is providing a hypertext link to the item shown above, but is not the author of the item (unless otherwise specified).|